Pharmacological Prevention of Peri-, and Post-Procedural Myocardial Injury in Percutaneous Coronary Intervention

E-ISSN： 1875-6557|4|3|223-230

ISSN： 1573-403X

Source： Current Cardiology Reviews, Vol.4, Iss.3, 2008-08, pp. : 223-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Management of No Reflow During Percutaneous Coronary Intervention

Current Vascular Pharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 95-100

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention

By Nageh T. Sherwood R.A. Harris B.M. Byrne J.A. Thomas M.R.

International Journal of Cardiology, Vol. 92, Iss. 2, 2003-12 ,pp. : 285-293

Elsevier

Access to resources Recommend Favorite

Current status of distal embolization in percutaneous coronary intervention: mechanical and pharmacological strategies

By Haeck Joost DE Verouden Niels JW Henriques José PS Koch Karel T

Future Cardiology, Vol. 5, Iss. 4, 2009-07 ,pp. : 385-402

Future Medicine

Access to resources Recommend Favorite

Distal myocardial protection during percutaneous coronary intervention with an intracoronary -blocker

By Wang F.W. Osman A. Otero J.

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 56-57

Elsevier

Access to resources Recommend Favorite

Myocardial Perfusion SPECT Imaging in Patients after Percutaneous Coronary Intervention

Current Cardiology Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 98-103

Bentham Science Publishers

Access to resources Recommend Favorite